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SUMMARY
Botulism is a rare and potentially lethal illness caused by Clostridium botulinum neurotoxin. We describe the findings of a 
laboratorial investigation of 117 suspected cases of botulism reported to the surveillance system in Brazil from January 2000 to 
October 2008. Data on the number and type of samples analyzed, type of toxins identified, reporting of the number of botulism 
cases and transmission sources are discussed. A total of 193 clinical samples and 81 food samples were analyzed for detection and 
identification of the botulism neurotoxin. Among the clinical samples, 22 (11.4%) presented the toxin (nine type A, five type AB and 
eight with an unidentified type); in food samples, eight (9.9%) were positive for the toxin (five type A, one type AB and two with an 
unidentified type). Of the 38 cases of suspected botulism in Brazil, 27 were confirmed by a mouse bioassay. Laboratorial botulism 
diagnosis is an important procedure to elucidate cases, especially food-borne botulism, to confirm clinical diagnosis and to identify 
toxins in food, helping sanitary control measures.
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INTRODUCTION
Botulism is a rare and severe illness that is potentially lethal if not 
treated rapidly. It is caused by Clostridium botulinum neurotoxin. Four 
clinical forms of botulism are described: food-borne, adult intestinal, 
infant and wound. Although rare, iatrogenic and inhalation forms have 
been described2,8. The incubation periods generally range from six 
hours to 10 days depending on the toxin quantity ingested, but it usually 
ranges from 18 to 36 hours. The clinical syndrome is characterized by 
symptoms and neurologic signs that upon onset can be nonspecific 
(headache, dizziness) before progressing to cranial nerve palsies followed 
by descending flaccid and symmetric muscle paralysis, which can cause 
respiratory failure and death. In food-borne botulism, the most common 
and important form in public health, gastrointestinal manifestations 
such as nausea, vomit, diarrhea or constipation can also occur at the 
onset of illness. Food-borne botulism is caused by the ingestion of food 
contaminated with the preformed toxin1,4,5,7. Therapy involves intensive 
care unit support to the patient to maintain vital conditions, with 
mechanical ventilation if needed, and administration of equine antitoxin 
to prevent the progression of neurologic symptoms13. 
Seven immunologically distinct toxins are produced as a result of 
C. botulinum spore germination (A, B, C1, D, E, F and G). Types A, 
B, E, and more rarely F, are responsible for most human cases12,16. In 
Brazil, reported cases of botulism were usually caused by toxins A or B 
and were related to commercially and home canned vegetables fruits or 
meat and other foods10. 
Laboratorial diagnosis of botulism is confirmed by the presence of 
toxin in clinical samples and/or leftovers of food previously consumed by 
patients. The standard tests employed for the detection and identification 
of botulinum neurotoxin are mouse toxicity and neutralization bioassay 
tests. Although other in vitro tests have been developed, none of them 
presented sensitivity and specificity in comparison to the bioassay, 
which is considered an efficient tool for toxin detection11,15. The Food 
Microbiology Section at the Adolfo Lutz Institute is the only laboratory 
in Brazil that has performed botulism diagnosis since 1982. In 2002, it 
was integrated into the National Laboratories Network for Epidemiologic 
Surveillance, performing botulism diagnosis in all national territories. 
This study reports the findings of a laboratorial investigation of 
suspected cases of botulism reported to the surveillance system in Brazil 
from January 2000 to October 2008 that are related to the detection and 
identification of botulinum toxins. 
MATERIAL AND METHODS
A total of 193 clinical samples (111 serum, 33 gastric contents, 39 
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feces, four viscera, three cerebrospinal fluid, one vomit, one wound 
exudates, one plasma) and 81 food samples from 117 suspected cases of 
botulism were analyzed in this period by the Food Microbiology Section 
of Adolfo Lutz Institute. Samples were taken from distinct Brazil states 
such as Amazonas, Bahia, Ceará, Goiás, Maranhão, Mato Grosso, Mato 
Grosso do Sul, Minas Gerais, Pará, Paraná, Pernambuco, Rio de Janeiro, 
Rio Grande do Norte, Rio Grande do Sul and São Paulo. 
Diagnosis was made by the mouse bioassay as described by 
KAUTTER et al. (1992)11 and SOLOMON et al. (2001)15. Briefly, 
white Swiss female mice (20-25 g) were used for the assay. Serum and 
cerebrospinal fluid were directly injected into two mice intraperitoneally; 
the other samples (gastric contents, feces, viscera, vomit and food) were 
prepared (toxin extraction), treated and injected into two mice. Mice 
were observed closely for the first six hours after inoculation and in 3-4 
h intervals thereafter for 96 h. When the bioassay was positive for toxic 
substances compatible with botulinum neurotoxin, the remaining material 
was submitted for the determination of toxin type by neutralization of the 
toxin with specific botulinum antiserum types A, B, E and F. In suspected 
cases of wound botulism, adult intestinal or infant botulism, samples 
were initially cultured for detection and isolation of C. botulinum and 
subsequently analyzed by the bioassay. 
RESULTS AND DISCUSSION
A total of 193 clinical samples and 81 food samples obtained from 
January 2000 to October 2008 were analyzed. Among clinical samples, 
22 (11.4%) presented the toxin, consisting of 17 (8.8%) serum, three 
(1.5%) feces and two (1.0%) gastric content samples. In food samples, 
eight (9.9%) were positive, consisting of home-canned meat, home pork 
liver pâté, industrialized canned liver pâté, canned tofu cream (soybean 
cheese), chicken pie with cheese cream, chicken pastry, chicken pie 
with peas and heart of palm and home-canned fish. In eight clinical 
(four serum, three feces and one gastric content) and two food (chicken 
pastry and home-canned fish) samples, toxin type identification was 
not possible. Among 117 suspected cases tested by our institution, 27 
(23.1%) were confirmed for botulism, consisting of 18 cases (66.7%) 
caused by type A toxin, five (18.5%) caused by type A and B and four 
cases (14.8%) by unidentified type (Table 1). Of 38 cases of suspected 
botulism in Brazil, 27 (71%) were confirmed by the mouse bioassay and 
11 cases (29%) by clinical-epidemiologic criteria (compatible clinical 
symptoms, electroneuromyography and/or epidemiologic links among 
cases from outbreaks). All samples submitted for cultures of C. botulinum 
were negative. 
The case-fatality rate for botulism was high, reaching 34.2% during 
the observation period. Botulism is rare, thus many physicians are 
unfamiliar with the disease. Therefore, patients with botulism can be 
misdiagnosed as having other illnesses such as Guillain-Barré Syndrome, 
Miller-Fisher Syndrome and myasthenia gravis, resulting in delays 
in the administration of botulinum antitoxin and increased mortality. 
Although botulism is typically rare, fatality can be high if the disease 
is not treated immediately. The high mortality rate is related to delayed 
clinical diagnosis, and respiratory failure is a major cause of death. A 
significant reduction in mortality is observed when patients are treated 
in hospital units with intensive therapy2.
The mouse bioassay is performed in a limited number of public 
health laboratories. From the time that mice are injected, final results 
may not be available for 24 or 48 h. Accordingly, all clinical management 
decisions and initial public health interventions are determined based 
solely on clinical diagnosis. The only specific treatment for botulism 
is the administration of botulinum antitoxin. Antitoxin should be given 
early in the course of illness, ideally < 24 h after the onset of symptoms, 
because antitoxin neutralizes only toxin molecules that are unbound to 
nerve endings14. 
Laboratorial diagnosis of botulinum neurotoxin has been fundamental 
to elucidating food-borne botulism, because these results can help to 
determine the contaminated food source. Although microorganism culture 
methods can be applied for the isolation of viable cells of C. botulinum 
in food or clinical samples, they are not sufficient to confirm the cause of 
illness, requiring interpretation of the results related to case definition in 
the epidemiologic investigation. C. botulinum spores are routinely ingested 
and excreted by humans without germination, toxin production, or any 
harm to the person through whom they pass. The exceptions are the small 
number of infants who develop infant botulism and the handful of adults 
who develop adult toxemic infectious botulism12. The demonstration of 
C. botulinum in patient stool samples or in cultures of wound material is 
generally satisfactory for the diagnosis of adult botulism syndromes and 
is considered definitive for the diagnosis of infant botulism14. 
This study showed that, as described in the scientific literature, 
in addition to home-canned meat and vegetables, several other food 
sources were implicated in outbreaks, including baked dishes containing 
stuffing, such as pie and pizza. The toxin in these foods was associated 
with several events of the production process: raw material contaminated 
with spores of C. botulinum, inadequate time/temperature applied to kill 
spores, destruction of competitive microorganisms and/or elimination of 
oxygen during cooking/roasting, germination and growth of vegetative 
cells, and toxin production during storage processes3,6,9,10,13. 
An outbreak associated with soybean cheese (tofu) was the first 
described in Brazil9 and was related to a commercial product imported 
from China. In the Unites States, similar cases have been reported that 
were associated with consumption of fermented tofu6. The development 
of C. botulinum and the production of toxin in tofu are propitiated by the 
neutral pH of the product, boiling (which creates anaerobic conditions) 
and the maintenance of room temperature (20-25 °C) before, during or 
after food preparation. In pâté samples, toxin production could occur 
due to incorrect handling and maintenance of food and could be due 
to a lack of nitrite, which is one of the principal measures utilized to 
control C. botulinum. 
In this study, 77.5% of suspected cases analyzed were negative for 
botulinum neurotoxin. The findings that were later confirmed by clinical-
epidemiologic criteria showed that the principal causes of misdiagnosis 
were delayed collection and inadequate quantities of samples to perform 
the bioassay. The remaining negative cases were discharged as botulism. 
The notification of suspected cases in Brazil has been compulsory 
since 2001, facilitating the development of epidemiologic and sanitary 
investigation and implementation of new sanitary measures to control 
and prevent this illness. Botulism laboratory diagnosis is an important 
basis for elucidating cases, especially cases of food-borne botulism, 
confirming the clinical diagnosis and identifying toxins in food, allowing 
for epidemiologic and sanitary surveillance for sanitary control measures. 
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Effective treatment depends on supportive intensive care and rapid 
administration of botulinum antitoxin based on clinical presentation, 
because laboratory diagnosis is time-consuming.
RESUMO
Botulismo no Brasil, 2000-2008: epidemiologia, achados clínicos e 
diagnóstico laboratorial
Botulismo é uma doença rara e potencialmente letal, resultante da 
ação de uma neurotoxina produzida pelo Clostridium botulinum. No 
presente estudo, estão descritos os resultados da investigação laboratorial 
de 117 casos suspeitos de botulismo notificados ao sistema de vigilância, 
ocorridos no Brasil no período de janeiro de 2000 a outubro de 2008. 
Os dados obtidos sobre as fontes de transmissão, os tipos de toxina 
identificados e de amostras analisadas serão discutidos. Foram analisadas 
193 amostras clínicas e 81 amostras de alimentos para detecção e 
identificação de neurotoxina botulínica. Entre as amostras clínicas, 22 
(11,4%) amostras apresentaram resultado positivo para toxina (nove do 
tipo A, cinco do tipo AB e em oito o tipo não foi identificado) e entre 
as amostras de alimentos, oito (9,9%) foram positivas (cinco do tipo A, 
uma do tipo AB e em duas o tipo não foi identificado). Dos 38 casos 
considerados positivos para botulismo, 27 foram confirmados pelo 
bioensaio em camundongo. O diagnóstico laboratorial de botulismo 
é importante para elucidação dos casos, principalmente de botulismo 
alimentar, para confirmação dos diagnósticos clínicos e identificação das 
toxinas nos alimentos, provendo subsídios para as medidas de controle 
sanitário.
Table 1 
Cases of botulism in Brazil, by state of residence, confirmed by laboratorial diagnosis from January 2000 to October 2008
Year State Cases (Gender ) 
Clinical samples 
(confirmed/analyzed)
Food samples 
(confirmed/analyzed)
Samples confirmed/identification 
of toxin type
2001 São Paulo 1 (M) 2/3 0/10 Serum and feces/Not enough material for identification of type
2002 Mato Grosso do Sul 3 (F)1 (M) 0/7 1/6 Home canned meat/Type A
2002 Ceará 1 (M) 0/0 1/2 Home canned liver pork pâté/Type A
2002 São Paulo 1 (M) 1/3 0/0 Serum/Type A
2002 Minas Gerais 1 (M) 2/2 0/8 Serum/Type AFeces/Not identified
2003 Bahia 1 (M) 1/3 0/1 Gastric contents/Type A and B
2004 Pernambuco 1 (M) 1/3 0/0 Serum/Type A and B
2004 Bahia 2 (M) 2/2 0/2 Serum/Type A
2005 Minas Gerais 1 (F) 2/3 1/1 Serum/Type AIndustrialized liver pâté/Type A
2005 Minas Gerais 1 (F) 1/3 0/0 Serum/Type A and B
2005 São Paulo 3 (F) 1 (M) 2/11 1/3
Serum/Not identified
Gastric contents/Not identified
Commercial canned soybean cheese(tofu)/Type A
2006 São Paulo 1 (M) 1/1 1/2 Serum/Type AChicken pie with cream cheese/Type A
2006 Rio Grande do Norte 1 (F) 1/2 0/1 Serum/Type A and B
2006 Ceará 3 (F) 2/3 1/1 Serum/Type AChicken pastry/Not identified
2007 São Paulo 1 (M) 1/1 1/1
Serum/Type A and B
Chicken pie with peas and hearts of palm/Type 
A and B
2007 São Paulo 1 (M) 1/2 0/0 Serum/Not identified
2007 São Paulo 1 (F) 1/3 1/2 Serum/Not identifiedHome comfit of fish/Not identified
2008 São Paulo 1 (M) 1/4 0/1 Feces/Not identified
F- female; M- male.
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